Navigation Links
FDA Approves Boston Scientific's Express(R) SD Renal Stent System
Date:12/15/2008

r things, statements regarding clinical trials, product performance, competitive offerings, procedural volume, overall market size and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary s
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
2. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
3. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
4. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
5. FDA Approves Durameds LoSEASONIQUE(R) Oral Contraceptive
6. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
7. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
8. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
9. FDA Approves Fougeras Clotrimazole Cream USP 1%
10. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
11. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 16, 2013 Kitware , ... today announces new Phase II SBIR funding from ... development of an open-source, high performance computing (HPC) ... framework enables researchers to select only the toolkits ... simulation, computation, or analysis tasks. , Manufacturers ...
(Date:5/16/2013)... May 16, 2013 Scientists at the Center ... , and the California -based ... a novel therapy for reversing memory decline in mice ... find significant cognitive improvement in advanced stage AD mice. ... for reversing cognitive decline for advanced stage AD mice, ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ...   Competitor Analysis: ... Biosuperiors http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The ...
(Date:5/16/2013)... DNA Genotek, a leading provider of products for biological ... in conjunction with the African Society of Human Genetics (AfSHG). ... the cost of DNA collection for locally and ... Health in Africa (H3 Africa) Initiative and to facilitate growth ... AfSHG is to build the capacity of African ...
Breaking Biology Technology:Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Insmed Inc. (Nasdaq:,INSM), a developer of follow-on ... a hearing before a Nasdaq Listing,Qualifications Panel to ... common stock from the Nasdaq Global Market., ... Market ("Nasdaq") on,December 20, 2007 indicating that the ...
... Resigns as President and CEO -, DALLAS, Dec. ... today that current Chairman Jeffrey B.,Davis has been appointed ... resigned as President and CEO of the Company for ... of Directors., "I believe that Access has an ...
... Dec. 26 The Ensign,Group, Inc. (Nasdaq: ENSG ... nursing, rehabilitative care services and assisted living,companies, today announced ... dividend of $0.04 per share of Ensign common stock, ... record as of December 31,2007. Ensign paid annual cash ...
Cached Biology Technology:Insmed to Appeal Delisting Notification From Nasdaq 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 3
(Date:5/16/2013)... May 16, 2013 The relationship between the ... has not been clear. Schizophrenia is commonly associated ... There are clues that reduced IQ may be ... example, reduced cognitive ability may precede the onset ... present in healthy relatives of people diagnosed with ...
(Date:5/16/2013)... Integrated Biometrics patented LES (Light Emitting ... film transistor camera introduces Sherlock, a fingerprint scanner ... the smallest and lightest form factor available on ... ID FAP 45, Certified scanner is highly efficient ... weight when compared to optical scanners. ...
(Date:5/16/2013)... million years old give unprecedented insight into the ... the most species-rich groups among the modern bony ... Reichenbacher from the Division of Paleontology and Geobiology ... at Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have ... they assign to the group of bony fishes ...
Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
... Stanford University researchers demonstrated for the first time ... (PET)/computed tomography (CT) images for "fly-through" and "fly-around ... according to a study in the July issue ... powerful ability to meld functional data with accurate ...
... people while they walk, researchers have improved our understanding of ... the same time, the researchers found that the stimulus could ... was walking straight ahead to be steered by "remote control" ... Richard Fitzpatrick and Jane E. Butler of the Prince of ...
... University of Cincinnati (UC) researchers say exposure to a ... we breathe every day--can make young children more susceptible ... The team found that infants who were exposed to ... in life were more likely to develop allergies to ...
Cached Biology News:Coming soon: 3-D imaging that flies 'through' and 'around' cancer 2Coming soon: 3-D imaging that flies 'through' and 'around' cancer 3Stimulation of the semicircular canals can artificially control human walking and balance 2Airborne mold spores increase kids' risk for multiple allergies 2
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
22 x 50 mm; No. 1 thickness range: 0.13 to 0.17 mm, suitable for work in histology, cytology, urinalysis and microbiology, precleaned, store at room temperature ...
Polyethylene Glycol 8000, 1 kg. PEG 8000.Used in differential DNA precipitation. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
See product name for description....
Biology Products: